Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Other financing activities (2017 - 2025)

AtriCure (ATRC) has disclosed Other financing activities for 13 consecutive years, with $6.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Other financing activities rose 484.66% to $6.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.2 million, a 484.66% increase, with the full-year FY2025 number at $6.2 million, up 484.66% from a year prior.
  • Other financing activities was $6.2 million for Q4 2025 at AtriCure, up from $1.1 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $10.2 million in Q2 2021 to a low of -$6.3 million in Q3 2021.
  • A 4-year average of $771818.2 and a median of $142000.0 in 2024 define the central range for Other financing activities.
  • Biggest YoY gain for Other financing activities was 117000.0% in 2021; the steepest drop was 22.45% in 2021.
  • AtriCure's Other financing activities stood at $1.2 million in 2021, then crashed by 105.12% to -$60000.0 in 2023, then skyrocketed by 1881.67% to $1.1 million in 2024, then surged by 484.66% to $6.2 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Other financing activities are $6.2 million (Q4 2025), $1.1 million (Q4 2024), and -$1.0 million (Q3 2024).